Y-Intercept (HK)’s Vor Biopharma VOR Stock Holding History

Y-Intercept (HK)’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-17,238	Closed	-$317K	–	2128
2026 Q2	$317K	Buy	+17,238	New	+$261K	0.01%	1452
2024 Q3	–	Sell	-6,615	Closed	-$132K	–	1844
2024 Q2	$132K	Buy	+6,615	New	+$214K	0.01%	1229

Other funds holding VOR

FIA

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Y-Intercept (HK)'s VOR Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Vor Biopharma (VOR) in Q3 2026, closing a stake of 17,238 shares — an estimated $317K sold.

Y-Intercept (HK) first reported a position in VOR in Q2 2024 and held it in 2 quarters. The position peaked at $317K in Q2 2026. 7 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

Y-Intercept (HK) reported no remaining Vor Biopharma position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 17,238 Vor Biopharma shares in Q3 2026, an estimated $317K.
Y-Intercept (HK) first reported a position in Vor Biopharma in Q2 2024 and held it in 2 quarters.
Y-Intercept (HK)'s Vor Biopharma position peaked at $317K in Q2 2026.
7 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.